Alicia Tosoni

<i>MGMT</i> Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

Alba A. Brandes, Enrico Franceschi, Alicia Tosoni et al. · Journal of Clinical Oncology · 2008 · 831 citations · Full text

Medicine, Oncology, Radiology +17

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Martin J. van den Bent, Alba A. Brandes, R. Rampling et al. · Journal of Clinical Oncology · 2009 · 569 citations · Full text

Medicine, Oncology, Pharmacology +17

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With <i>MGMT</i> Promoter Methylation Status

Alba A. Brandes, Alicia Tosoni, Enrico Franceschi et al. · Journal of Clinical Oncology · 2009 · 384 citations

Medicine, Oncology, Radiation Oncology +17

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma

Alba A. Brandes, Enrico Franceschi, Alicia Tosoni et al. · Cancer · 2009 · 221 citations

Medicine, Oncology, Pharmacology +17

CXCR3 and Its Ligand CXCL10 Are Expressed by Inflammatory Cells Infiltrating Lung Allografts and Mediate Chemotaxis of T Cells at Sites of Rejection

Carlo Agostini, Fiorella Calabrese, Federico Rea et al. · American Journal Of Pathology · 2001 · 207 citations

Life Sciences, Cell Biology, Immunology +17